0 of 11 Questions completed
Questions:
You have already completed the quiz before. Hence you can not start it again.
Quiz is loading...
You must sign in or sign up to start the quiz.
You must first complete the following:
0 of 11 Questions answered correctly
Your time:
Time has elapsed
You have reached 0 of 0 point(s), (0)
Earned Point(s): 0 of 0, (0)
0 Essay(s) Pending (Possible Point(s): 0)
Looks like you did not reach 70% on this quiz. Give it another shot.
You passed this quiz. Great job!
The United States Food and Drug Administration (FDA) approved a new HIV test, one that can be done without using a needle. This test is used today in 2018. This test, called the OraQuick Rapid HIV Test for Oral Fluid, provides results in 20 minutes using saliva. The OraQuick Rapid Advance Test is used to test for HIV-2. The most common HIV test is the antibody screening test (immunoassay), which tests for the antibodies that your body makes against HIV. The immunoassay may be conducted in a lab or as a rapid test at the testing site. It may be performed on blood or oral fluid (not saliva). Because the level of antibody in oral fluid is lower than it is in blood, blood tests tend to find infection sooner after exposure than do oral fluid tests. In addition, most blood-based lab tests find infection sooner after exposure than rapid HIV tests.
The most common HIV test is the antibody screening test (immunoassay), which tests for the antibodies that your body makes against HIV. The immunoassay may be conducted in a lab or as a rapid test at the testing site. It may be performed on blood or oral fluid (not saliva). Because the level of antibody in oral fluid is lower than it is in blood, blood tests tend to find infection sooner after exposure than do oral fluid tests. In addition, most blood-based lab tests find infection sooner after exposure than rapid HIV tests. The rapid test is an immunoassay used for screening, and it produces quick results, in 30 minutes or less. Rapid tests use blood or oral fluid to look for antibodies to HIV. If an immunoassay (lab test or rapid test) is conducted during the window period (i.e., the period after exposure but before the test can find antibodies), the test may not find antibodies and may give a false-negative result. All immunoassays that are positive need a follow-up test to confirm the result.
The most common HIV test is the antibody screening test (immunoassay), which tests for the antibodies that your body makes against HIV. The immunoassay may be conducted in a lab or as a rapid test at the testing site. It may be performed on blood or oral fluid (not saliva). Because the level of antibody in oral fluid is lower than it is in blood, blood tests tend to find infection sooner after exposure than do oral fluid tests. In addition, most blood-based lab tests find infection sooner after exposure than rapid HIV tests. The rapid test is an immunoassay used for screening, and it produces quick results, in 30 minutes or less. Rapid tests use blood or oral fluid to look for antibodies to HIV. If an immunoassay (lab test or rapid test) is conducted during the window period (i.e., the period after exposure but before the test can find antibodies), the test may not find antibodies and may give a false-negative result. All immunoassays that are positive need a follow-up test to confirm the result.
The most common HIV test is the antibody screening test (immunoassay), which tests for the antibodies that your body makes against HIV. The immunoassay may be conducted in a lab or as a rapid test at the testing site. It may be performed on blood or oral fluid (not saliva). Because the level of antibody in oral fluid is lower than it is in blood, blood tests tend to find infection sooner after exposure than do oral fluid tests. In addition, most blood-based lab tests find infection sooner after exposure than rapid HIV tests. The rapid test is an immunoassay used for screening, and it produces quick results, in 30 minutes or less. Rapid tests use blood or oral fluid to look for antibodies to HIV. If an immunoassay (lab test or rapid test) is conducted during the window period (i.e., the period after exposure but before the test can find antibodies), the test may not find antibodies and may give a false-negative result. All immunoassays that are positive need a follow-up test to confirm the result.
The rapid test is an immunoassay used for screening, and it produces quick results, in 30 minutes or less. Rapid tests use blood or oral fluid to look for antibodies to HIV. If an immunoassay (lab test or rapid test) is conducted during the window period (i.e., the period after exposure but before the test can find antibodies), the test may not find antibodies and may give a false-negative result. All immunoassays that are positive need a follow-up test to confirm the result. The United States Food and Drug Administration (FDA) approved a new HIV test, one that can be done without using a needle. This test is used today in 2018. This test, called the OraQuick Rapid HIV Test for Oral Fluid, provides results in 20 minutes using saliva. The OraQuick Rapid Advance Test is used to test for HIV-2.
Patients must be informed of the results of testing. In the case of a positive test for HIV infection, a patient must also be told that additional tests are necessary to confirm the results. If the results of HIV testing are positive, California law requires that healthcare providers report the results to the local health department HIV surveillance program. Healthcare providers are required to notify the patient’s sexual partners or needle-sharing partners of possible exposure to HIV infection. Verbal consent is required after a medical care provider tells a patient that an HIV test should be performed. If the patient declines to take the test, the provider must note this in the patient’s file.
Verbal consent is required after a medical care provider tells a patient that an HIV test should be performed. If the patient declines to take the test, the provider must note this in the patient’s file. Patients must be informed of the results of testing. In the case of a positive test for HIV infection, a patient must also be told that additional tests are necessary to confirm the results. If the results of HIV testing are positive, California law requires that healthcare providers report the results to the local health department HIV surveillance program. Healthcare providers are required to notify the patient’s sexual partners or needle-sharing partners of possible exposure to HIV infection.
Patients must be informed of the results of testing. In the case of a positive test for HIV infection, a patient must also be told that additional tests are necessary to confirm the results. If the results of HIV testing are positive, California law requires that healthcare providers report the results to the local health department HIV surveillance program. Healthcare providers are required to notify the patient’s sexual partners or needle-sharing partners of possible exposure to HIV infection. If a patient has a confirmed HIV positive test, healthcare providers must offer counseling that addresses management of infection, risk reduction, psychosocial issues, and notification of partners.
See video: Take-Home HIV Test OraQuick Approved for Use in US
See video: Take-Home HIV Test OraQuick Approved for Use in US
